# Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive

> **NCT01225614** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 77 (actual)

## Conditions studied

- Myopathy
- Muscular Weakness
- Respiratory Insufficiency

## Interventions

- **DEVICE:** Bilevel pressure ventilator

## Key facts

- **NCT ID:** NCT01225614
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2017-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225614, "Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01225614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*